Decision Making SIG

Objectives

The Quantitative Decision-making Special Interest Group (QDM SIG) was formed in October 2017. It is a group of statisticians from industry and academia, with experience and interests in statistical methods for quantitative decision-making in drug development. The objectives of the SIG are:

  • To share (anonymized) case studies of how quantitative decision-making methods have been used within pharmaceutical companies, for decisions at the trial level, at the development level and at the portfolio level
  • To perform literature reviews, discuss and make recommendations on existing methodologies in terms of approach and interpretation
  • To develop new methodologies or practices where needed
  • To promote the role of the statistician in supporting decision-making in pharmaceutical companies and/or other stakeholders
  • To propose trainings, public meetings or publications to share methods and experience

Who we are

Thomas Blondel (Ceva)
Nicolas Bonnet (Sanofi)
Daniel Bratton (GSK)
Sarah Bray (Amgen)
Alex Carlton (GSK) (Co-Chair)
Jacquie Christie (Sobi)
Paul Frewer (AstraZeneca)
Heiko Goette (Merck)
Tadhg Guerin (Theravance) (Co-Chair)
Kimberley Hacquoil (Exploristics)
Martin Johnson (UCB Pharma)
Kevin Kunzmann (Boehringer Ingelheim)
John-Philip Lawo (CSL Behring)
Daniel Leibovitz (Incyte)
Jesper Madsen (Novo Nordisk)
Pavel Mozgunov (Cambridge University)
Emmanuel Pham (Nova Discovery)
Gustaf Rydevik (UCB Pharma)
Gaëlle Saint-Hilary (Saryga)
Guido Thömmes (Grunenthal)
Katie Thorn (GSK)
Stefano Vezzoli (Chiesi Farmaceutici)
Stig Johan Wiklund

How to get in touch

For further information, or to join the QDM SIG, please contact our Co-Chairs:

Alex Carlton (GSK) alex.l.carlton@gsk.com
Tadhg Guerin (Theravance) tguerin@theravance.com


Latest News

...

Upcoming Events

...
EFSPI_Logo

Upcoming Events

PSI VisSIG Wonderful Wednesday Webinar Series (2023)

Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.

PSI Pre-Clinical SIG Webinar: End-user Tool for Immunogenicity Cut-points Calculation

This webinar will discuss the development of an adaptable yet fully automated end-user tool that allows a harmonized and regulatory compliant calculation and evaluation of immunogenicity cut-points. This will be followed by Q&A.

PSI Book Club

Welcome to PSI's book club! We will be reading/discussing non-technical books relevant to our roles. Participants will be split into smaller groups to network with each other and practice exercises.

PSI EIWG Webinar: Proposing Estimands from Different Perspectives

The webinar will build on the concepts and case studies previously discussed. A case study in heart failure will be presented from the perspective of multiple stakeholders.

Latest Jobs

Apprentice Biostatistician

The Apprentice Biostatistician splits their time between working for Parexel and performing studies with a university to obtain a MSc in Statistics over a period of three years.

Manager Statistical Programming (m/f/x)

For our headquarters in Munich we are seeking highly qualified candidates to apply for Manager Statistical Programming (m/f/x).